Search research articles
Contact Us
Filters
Showing results (71-80 of 100) with videos related to
Page
of 10
Sort By:
The Journal of Pharmacology and Experimental Therapeutics
|
June 3, 2011
Characterization of a sphingosine 1-phosphate receptor antagonist prodrug
Perry C Kennedy, Ran Zhu, Tao Huang, et al.
ACS Medicinal Chemistry Letters
|
May 19, 2016
Structural Requirements and Docking Analysis of Amidine-Based Sphingosine Kinase 1 Inhibitors Containing Oxadiazoles
Joseph D Houck, Thomas K Dawson, Andrew J Kennedy, et al.
Bioorganic & Medicinal Chemistry
|
July 28, 2009
Synthesis and biological evaluation of sphingosine kinase substrates as sphingosine-1-phosphate receptor prodrugs
Frank W Foss, Thomas P Mathews, Yugesh Kharel, et al.
Bioorganic & Medicinal Chemistry
|
January 1, 2021
Lipophilic tail modifications of 2-(hydroxymethyl)pyrrolidine scaffold reveal dual sphingosine kinase 1 and 2 inhibitors
Hao Li, Christopher D Sibley, Yugesh Kharel, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 3, 2012
Dendritic cell sphingosine 1-phosphate receptor-3 regulates Th1-Th2 polarity in kidney ischemia-reperfusion injury
Amandeep Bajwa, Liping Huang, Hong Ye, et al.
Journal of the American Society of Nephrology : JASN
|
March 11, 2016
Endothelial Sphingosine 1‑Phosphate Receptor‑1 Mediates Protection and Recovery from Acute Kidney Injury
Heather M Perry, Liping Huang, Hong Ye, et al.
Journal of Medicinal Chemistry
|
July 2, 2024
Discovery of Potent, Orally Bioavailable Sphingosine-1-Phosphate Transporter (Spns2) Inhibitors
Daniel J Foster, Kyle Dunnavant, Christopher W Shrader, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
April 26, 2015
Sphingosine-1-phosphate receptor 1 agonism attenuates lung ischemia-reperfusion injury
Matthew L Stone, Ashish K Sharma, Yunge Zhao, et al.
Journal of Medicinal Chemistry
|
April 19, 2011
Development of amidine-based sphingosine kinase 1 nanomolar inhibitors and reduction of sphingosine 1-phosphate in human leukemia cells
Andrew J Kennedy, Thomas P Mathews, Yugesh Kharel, et al.
Plos One
|
April 20, 2018
Saccharomyces cerevisiae as a platform for assessing sphingolipid lipid kinase inhibitors
Yugesh Kharel, Sayeh Agah, Tao Huang, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 100) with videos related to
Sort By:
Page
of 10
The Journal of Pharmacology and Experimental Therapeutics
|
June 3, 2011
Characterization of a sphingosine 1-phosphate receptor antagonist prodrug
Perry C Kennedy, Ran Zhu, Tao Huang, et al.
ACS Medicinal Chemistry Letters
|
May 19, 2016
Structural Requirements and Docking Analysis of Amidine-Based Sphingosine Kinase 1 Inhibitors Containing Oxadiazoles
Joseph D Houck, Thomas K Dawson, Andrew J Kennedy, et al.
Bioorganic & Medicinal Chemistry
|
July 28, 2009
Synthesis and biological evaluation of sphingosine kinase substrates as sphingosine-1-phosphate receptor prodrugs
Frank W Foss, Thomas P Mathews, Yugesh Kharel, et al.
Bioorganic & Medicinal Chemistry
|
January 1, 2021
Lipophilic tail modifications of 2-(hydroxymethyl)pyrrolidine scaffold reveal dual sphingosine kinase 1 and 2 inhibitors
Hao Li, Christopher D Sibley, Yugesh Kharel, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 3, 2012
Dendritic cell sphingosine 1-phosphate receptor-3 regulates Th1-Th2 polarity in kidney ischemia-reperfusion injury
Amandeep Bajwa, Liping Huang, Hong Ye, et al.
Journal of the American Society of Nephrology : JASN
|
March 11, 2016
Endothelial Sphingosine 1‑Phosphate Receptor‑1 Mediates Protection and Recovery from Acute Kidney Injury
Heather M Perry, Liping Huang, Hong Ye, et al.
Journal of Medicinal Chemistry
|
July 2, 2024
Discovery of Potent, Orally Bioavailable Sphingosine-1-Phosphate Transporter (Spns2) Inhibitors
Daniel J Foster, Kyle Dunnavant, Christopher W Shrader, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
April 26, 2015
Sphingosine-1-phosphate receptor 1 agonism attenuates lung ischemia-reperfusion injury
Matthew L Stone, Ashish K Sharma, Yunge Zhao, et al.
Journal of Medicinal Chemistry
|
April 19, 2011
Development of amidine-based sphingosine kinase 1 nanomolar inhibitors and reduction of sphingosine 1-phosphate in human leukemia cells
Andrew J Kennedy, Thomas P Mathews, Yugesh Kharel, et al.
Plos One
|
April 20, 2018
Saccharomyces cerevisiae as a platform for assessing sphingolipid lipid kinase inhibitors
Yugesh Kharel, Sayeh Agah, Tao Huang, et al.
Page
of 10